EN
HI
Summary
As of 10 Oct, 2026, Gland Pharma stock price is ₹3061.8. During the trading session, the stock has moved between an intraday low of ₹3008.20 and an intraday high of ₹3121.90. Over the last 52 weeks, Gland Pharma has traded between ₹1573.60 and ₹3171.00.
The stock has recorded a trading volume of 1,81,216 shares,. Its Average Traded Price (ATP) is ₹3067.93, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹3061.80.
Gland Pharma has an upper circuit limit of ₹3674.10 and a lower circuit limit of ₹2449.50. The total value traded stands at ₹55.60 CR, and the delivery percentage for the day is 46.84%.
The stock is currently traded with a market lot size of 1. Gland Pharma also offers a dividend yield of 0.65%.
Gland Pharma Share Price Chart
Gland Pharma Share Key Metrics
Volume
1.81 L
Market Cap
50523.02 CR
LTQ@LTP
1@3061.80
ATP
3067.93
Var Margin
17.11 %
Circuit Range
2449.5-3674.1
Delivery %
46.84 %
Value
55.60 CR
ASM/GSM
No
Market Lot
1
Gland Pharma Fundamentals
P/E Ratio
44.76
P/B Ratio
4.75
Div. Yield
0.65
Sector P/E
41.33
Sector P/B
3.47
Sec. Div. Yield
0.53
Gland Pharma Resistance and Support
Pivot 3099.7
Resistance
First Resistance
3149.9
Second Resistance
3220.7
Third Resistance
3270.9
Support
First Support
3028.9
Second Support
2978.7
Third Support
2907.9
Gland Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 09 2026 | 3059.1 | 3061.8 | -0.56% | 3121.9 | 3008.2 |
| Thu Oct 08 2026 | 3162 | 3079.1 | -2.27% | 3170.5 | 3049.5 |
| Wed Oct 07 2026 | 3026 | 3150.6 | 4.81% | 3171 | 3019 |
Gland Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-11-04 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
Gland Pharma News
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Gland Pharma approved a USD 21 million investment through its wholly-owned US subsidiary to acquire a 60% stake in Novelstar Pharma Inc. The newly incorporated target, co-owned 40% by Fosun Pharma USA, will help facilitate the company's strategic expansion in the United States.
Oct 01 2026 15:51:40
Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting - 01-10-2026
Gland Pharma approved a USD 21 million investment through its US subsidiary to acquire a 60% stake in Novelstar Pharma. The move aims to expand the company's business in the US market. The cash transaction is expected to close by October 2026, with Fosun USA holding the remaining 40% stake.
Oct 01 2026 15:45:16
Gland Pharma Management
| Name | Position |
|---|---|
| Sampath Kumar Pallerlamudi | Company Secretary & Compliance Officer |
| Srinivas Sadu | Chairman |
Gland Pharma Similar Stocks
Alkem Laboratories Ltd.
5279.00
29.50 (0.56%)
Aster DM Quality Care Ltd.
699.85
22.70 (3.35%)
Fortis Healthcare Ltd.
786.25
23.25 (3.05%)
Biocon Ltd.
349.40
-0.60 (0.17%)
Abbott India Ltd.
26000.00
420.00 (1.64%)
Anthem Biosciences Ltd.
862.30
-10.25 (1.17%)
Ipca Laboratories Ltd.
1915.40
-23.00 (1.19%)
Glaxosmithkline Pharmaceuticals Ltd.
2540.30
5.90 (0.23%)
Ajanta Pharma Ltd.
3410.10
-25.50 (0.74%)
Gland Pharma FAQs
The Buying Price of Gland Pharma share is 3061.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gland Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gland Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gland Pharma shares is 44.76. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gland Pharma shares is 4.75. Useful to assess the stock's value relative to its book value.
To assess Gland Pharma’s valuation compare Sector P/E, P/B which are 41.33 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gland Pharma is 50523.02 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gland Pharma share price is 3171.00 & 1573.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gland Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLAND
